Key result
Losartan, aspirin, and atorvastatin decrease vascular wall thickness and plasma biomarkers in juvenile hypertensive rats.
Why the study?
Hypertension in adolescents is linked to adverse cardiovascular events, but whether pharmacological therapy in early life improves vascular remodeling beyond lowering blood pressure is unclear.
Does long-term administration of losartan, aspirin, and atorvastatin improve vascular remodeling in juvenile spontaneously hypertensive rats?
Does long-term administration of losartan, aspirin, and atorvastatin improve vascular remodeling in juvenile spontaneously hypertensive rats?
Long-term pharmacological therapy with losartan, aspirin, and atorvastatin improves vascular remodeling and reduces inflammatory and neurohormonal markers in a juvenile hypertensive rat model.
Hypothesis-generating for early vascular remodeling in hypertension; human trials needed before any clinical consideration.
Hypertension in adolescents is associated with adverse cardiac and vascular events. In addition to lowering blood pressure, it is not clear whether pharmacological therapy in early life can improve vascular remodeling. This study aimed to evaluate the effects of long-term administration of losartan, aspirin, and atorvastatin on vascular remodeling in juvenile spontaneously hypertensive rats (SHRs). Losartan, aspirin, and atorvastatin were administered via gavage at doses of 20, 10, and 10 mg/kg/day, respectively, on SHRs aged 6-22 weeks. Paraffin sections of the blood vessels were stained with hematoxylin-eosin (H&E) and Sirius Red to evaluate the changes in the vascular structure and the accumulation of different types of collagen. The plasma levels of renin, angiotensin II (Ang II), aldosterone (ALD), endothelin-1 (ET-1), interleukin-6 (IL-6), and neutrophil elastase (NE) were determined using ELISA kits. After the 16-week treatment with losartan, aspirin, and atorvastatin, the wall thickness of the thoracic aorta and carotid artery decreased. The integrity of the elastic fibers in the tunica media was maintained in an orderly manner, and collagen deposition in the adventitia was retarded. The plasma levels of renin, ALD, ET-1, IL-6, and NE in the SHRs also decreased. These findings suggest that losartan, aspirin, and atorvastatin could improve vascular remodeling beyond their antihypertensive, anti-inflammatory, and lipid-lowering effects. Many aspects of the protection provided by pharmacological therapy are important for the prevention of cardiovascular diseases in adults and older adults.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2023) studied Hypertension. Losartan, aspirin, and atorvastatin was evaluated on Vascular remodeling and plasma levels of renin, Ang II, ALD, ET-1, IL-6, and NE. A 16-week treatment with losartan, aspirin, and atorvastatin decreased aortic and carotid wall thickness and reduced plasma renin, ALD, ET-1, IL-6, and NE in juvenile spontaneously hypertensive rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: